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Synthesis of protocatechuic acid–zinc/aluminium–layered double hydroxide 
nanocomposite as an anticancer nanodelivery system 
 
ABSTRACT 
Protocatechuic acid, an active anticancer agent, has been intercalated into Zn/Al–layered 
double hydroxide at Zn/Al=2) using two different preparation methods, co-precipitation and 
ion-exchange, which are labelled as PZAE and PZAC, respectively. The release of 
protocatechuate from the nanocomposites occurred in a controlled manner and was fitted 
satisfactorily to pseudo-second order kinetics. The basal spacing of the resulting 
nanocomposites PZAE and PZAC was 10.2 and 11.0 Å, respectively, indicating successful 
intercalation of protocatechuate anions into the interlayer galleries of Zn/Al–NO3–LDH in a 
monolayer arrangement with angles of 24 and 33° from the z-axis in PZAE and PZAC, 
respectively. The formation of nanocomposites was further confirmed by a Fourier transform 
infrared study. Thermogravimetric and differential thermogravimetric analyses indicated that 
the thermal stability of the intercalated protocatechuic acid was significantly enhanced 
compared to its free protocatechuic acid, and the drug content in the nanocomposites was 
estimated to be approximately 32.6% in PZAE and 29.2% in PZAC. Both PZAE and PZAC 
nanocomposites inhibit the growth of human cervical, liver and colorectal cancer cell lines 
and exhibit no toxic effects towards normal fibroblast 3T3 cell after 72 h of treatment. 
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